Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMC 1495583)

Published in J Gen Intern Med on August 01, 2000

Authors

M T Connelly1, M Richardson, R Platt

Author Affiliations

1: Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts, USA. maureen_connelly@hphc.org

Articles cited by this

Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med (1992) 12.89

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66

The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med (1993) 4.04

Association of exogenous estrogen and endometrial carcinoma. N Engl J Med (1975) 3.89

Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med (1996) 3.35

Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med (1999) 2.84

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med (1995) 2.58

Decreased mortality in users of estrogen replacement therapy. Arch Intern Med (1991) 2.26

Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE) J Am Geriatr Soc (1996) 2.17

Personal use of postmenopausal hormone replacement therapy by women physicians in the United States. Ann Intern Med (1997) 1.92

Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynaecol (1992) 1.74

Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol (1997) 1.63

Effect of physician gender on the prescription of estrogen replacement therapy. J Gen Intern Med (1996) 1.63

Randomized trial of osteoporosis screening. Use of hormone replacement therapy and quality-of-life results. Arch Intern Med (1997) 1.53

Correlates of postmenopausal female hormone use among black women in the United States. Obstet Gynecol (1998) 1.49

Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol (1990) 1.49

Hormone replacement therapy: compliance and cost after screening for osteoporosis. Eur J Obstet Gynecol Reprod Biol (1995) 1.45

Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol (1983) 1.45

Estrogen replacement therapy. A survey of women's knowledge and attitudes. Arch Intern Med (1989) 1.42

Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med (1992) 1.33

Prevalence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gynaecol (1997) 1.31

Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy. Br J Gen Pract (1995) 1.21

The use of hormone replacement therapy; results of a community survey. Fam Pract (1995) 1.16

Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol (1997) 1.15

Compliance with hormonal replacement therapy. Maturitas (1991) 1.08

Attitudes of women toward hormone therapy and prevention of heart disease. Am Heart J (1995) 1.07

Can we improve compliance with long-term HRT? Maturitas (1992) 1.04

Patterns and determinants of conjugated estrogen use. Am J Epidemiol (1979) 1.02

Are women using postmenopausal estrogens? A community survey. Am J Public Health (1990) 1.00

Has the climacteric been medicalized? A study on the use of medication for climacteric complaints in four countries. Maturitas (1992) 0.96

Compliance with long-term oral hormonal replacement therapy. Maturitas (1995) 0.96

Cross-national study of women's use of hormone replacement therapy (HRT) in Europe. Int J Fertil Womens Med (1997) 0.94

The menopausal transition; the use of estrogen. Can J Public Health (1986) 0.94

Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol (1994) 0.93

Compliance considerations with estrogen replacement: withdrawal bleeding and other factors. Am J Obstet Gynecol (1989) 0.93

Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol (1993) 0.91

Estrogen and progestin therapy to prevent osteoporosis: attitudes and practices of general internists and gynecologists. J Gen Intern Med (1991) 0.91

Menarche, menopause, and intervening fecundability. Hum Biol (1974) 0.91

Study of general practice consultations and menopausal problems. Oxford General Practitioners Menopause Study Group. BMJ (1991) 0.89

Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance. Obstet Gynecol (1997) 0.89

Use of postmenopausal hormone replacement therapy by African American women. The importance of physician discussion. Arch Intern Med (1997) 0.88

Enhancing patient compliance with hormone replacement therapy at menopause. Obstet Gynecol (1990) 0.87

Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre. Maturitas (1994) 0.86

Hormone replacement therapy: use patterns in 51-year-old Danish women. Maturitas (1990) 0.85

A case-control study of myocardial infarction in relation to use of estrogen supplements. Am J Epidemiol (1993) 0.84

Older women and hormone replacement therapy: factors influencing late life initiation. J Am Geriatr Soc (1997) 0.84

The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population. Acta Obstet Gynecol Scand (1997) 0.84

Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient. Am J Obstet Gynecol (1990) 0.83

Changes in the use of hormone replacement therapy in South Australia. Med J Aust (1995) 0.81

Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update (1997) 0.81

Compliance with hormone replacement therapy: are women receiving the full impact of hormone replacement therapy preventive health benefits? Womens Health Issues (1992) 0.81

Psychosocial factors associated with the use of hormonal replacement therapy in a longitudinal follow-up of Swedish women. Maturitas (1997) 0.80

Management of hormone replacement therapy: the Swedish experience. Eur J Obstet Gynecol Reprod Biol (1996) 0.79

Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. Am J Obstet Gynecol (1995) 0.79

Use of hormone replacement therapy by Melbourne women. Aust J Public Health (1995) 0.78

Perceptions of menopausal stage and patterns of hormone replacement therapy use. J Womens Health (1997) 0.78

Postmenopausal estrogen use among African American and white patients at an urban clinic. J Womens Health (1997) 0.78

Compliance difficulties with progestin-supplemented estrogen replacement therapy. J Fam Pract (1984) 0.77

The climacteric in The Netherlands: a review of Dutch studies on epidemiology, attitudes and use of hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol (1996) 0.77

Estrogen replacement therapy: what the future holds. Am J Obstet Gynecol (1989) 0.77

Articles by these authors

(truncated to the top 100)

The amino acid sequence of leghaemoglobin I from root nodules of broad bean (Vicia faba L.). FEBS Lett (1975) 9.08

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med (1999) 8.80

Three abundance classes in HeLa cell messenger RNA. Nature (1974) 6.79

Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA (1997) 4.49

Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care (1999) 4.35

Using automated medical records for rapid identification of illness syndromes (syndromic surveillance): the example of lower respiratory infection. BMC Public Health (2001) 4.05

The incidence of herpes zoster. Arch Intern Med (1995) 3.87

Contraindicated use of cisapride: impact of food and drug administration regulatory action. JAMA (2000) 3.81

Weekend hospitalization and additional risk of death: an analysis of inpatient data. J R Soc Med (2012) 3.77

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med (1995) 3.29

Microevolution of the direct repeat region of Mycobacterium tuberculosis: implications for interpretation of spoligotyping data. J Clin Microbiol (2002) 3.12

DNA-RNA hybridization in vast DNA excess. Nat New Biol (1971) 3.05

Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages. Am J Pathol (1979) 3.04

Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial. J Am Med Inform Assoc (1998) 2.96

Cutaneous disease and drug reactions in HIV infection. N Engl J Med (1993) 2.89

Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J Pediatr (1994) 2.79

Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med (1990) 2.78

The Newbury Maternity Care Study: a randomized controlled trial to assess a policy of women holding their own obstetric records. Br J Obstet Gynaecol (1987) 2.78

Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol (2001) 2.67

A model-adjusted space-time scan statistic with an application to syndromic surveillance. Epidemiol Infect (2005) 2.65

Classification of drug-resistant tuberculosis in an epidemic area. Lancet (2000) 2.62

Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis (2001) 2.51

Impacted third molars. Br Dent J (1995) 2.49

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47

Inhaled steroids and the risk of hospitalization for asthma. JAMA (1997) 2.45

Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics (2001) 2.41

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect (2011) 2.38

Incidental lesions found on CT colonography: their nature and frequency. Br J Radiol (2005) 2.37

Unexpectedly high strain diversity of Mycobacterium tuberculosis in a high-incidence community. S Afr Med J (1996) 2.35

Surgical site infections occurring after hospital discharge. J Infect Dis (1996) 2.35

Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients. J Infect Dis (1999) 2.31

Mortality associated with nosocomial urinary-tract infection. N Engl J Med (1982) 2.23

Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med (1998) 2.21

Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet (2000) 2.17

Thoughts on teaching medicine. Br Med J (1965) 2.17

Serious falls in hospitalized patients: correlates and resource utilization. Am J Med (1995) 2.15

The epidemiology of varicella and its complications. J Infect Dis (1995) 2.10

MRI of Hoffa's fat pad. Skeletal Radiol (2004) 2.07

Big money for big ideas: medical research in Texas. Tex Med (1992) 2.02

Antimicrobial use in defined populations of infants and young children. Arch Pediatr Adolesc Med (2000) 2.01

A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation (1992) 1.98

Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis (1994) 1.96

Mapping of IS6110 flanking regions in clinical isolates of Mycobacterium tuberculosis demonstrates genome plasticity. Mol Microbiol (2000) 1.92

Reforming the core clerkship in internal medicine: the SGIM/CDIM Project. Society of General Internal Medicine/Clerkship Directors in Internal Medicine. Ann Intern Med (2001) 1.91

An algorithm to match registries with minimal disclosure of individual identities. Public Health Rep (1999) 1.90

Stimulation of fructose transport across the intestinal brush-border membrane by PMA is mediated by GLUT2 and dynamically regulated by protein kinase C. Biochem J (2000) 1.89

Supplementing tuberculosis surveillance with automated data from health maintenance organizations. Emerg Infect Dis (2000) 1.86

Does routine intraoperative cholangiography prevent bile duct transection? Surg Endosc (2005) 1.85

Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis (1991) 1.84

Complementation of snf1, a mutation affecting global regulation of carbon metabolism in yeast, by a plant protein kinase cDNA. Proc Natl Acad Sci U S A (1991) 1.83

The sequelae of herpes zoster. Arch Intern Med (1997) 1.82

Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy. Antimicrob Agents Chemother (1981) 1.81

Nutrition interventions for intensive therapy in the Diabetes Control and Complications Trial. The DCCT Research Group. J Am Diet Assoc (1993) 1.80

Risk factors for postherpetic neuralgia. Arch Intern Med (1997) 1.79

Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis (2000) 1.79

Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tuber Lung Dis (1999) 1.77

A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab (1999) 1.75

Prospective randomized double-blind trial between laparoscopic Nissen fundoplication and anterior partial fundoplication. Br J Surg (1999) 1.75

Clonal expansion of a globally disseminated lineage of Mycobacterium tuberculosis with low IS6110 copy numbers. J Clin Microbiol (2004) 1.73

National Bioterrorism Syndromic Surveillance Demonstration Program. MMWR Morb Mortal Wkly Rep (2004) 1.73

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect (2014) 1.70

Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation (1999) 1.69

Disruption of coding regions by IS6110 insertion in Mycobacterium tuberculosis. Tuber Lung Dis (1999) 1.67

Regulation of GLUT5, GLUT2 and intestinal brush-border fructose absorption by the extracellular signal-regulated kinase, p38 mitogen-activated kinase and phosphatidylinositol 3-kinase intracellular signalling pathways: implications for adaptation to diabetes. Biochem J (2000) 1.67

Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. J Hum Virol (1999) 1.65

The amino acid sequence of sesame (Sesamum indicum L.) and castor (Ricinus communis L.) cytochrome c. Biochem J (1971) 1.64

An improved method for the purification of cytochrome c from higher plants. J Biochem (1971) 1.63

Calculation of the stability of the IS6110 banding pattern in patients with persistent Mycobacterium tuberculosis disease. J Clin Microbiol (2002) 1.62

The biopsychosocial model of general practice: rhetoric or reality? Br J Gen Pract (1996) 1.62

An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension. Eur Heart J (1997) 1.59

Endothelial cell morphology in areas of in vivo Evans blue uptake in the aorta of young pigs. II. Ultrastructure of the intima in areas of differing permeability to proteins. Am J Pathol (1977) 1.59

[35S]t-butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to gamma-aminobutyric acid-A and ion recognition sites. Mol Pharmacol (1983) 1.59

Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet (1999) 1.57

Panfungal PCR and multiplex liquid hybridization for detection of fungi in tissue specimens. J Clin Microbiol (2000) 1.57

Evolution of the IS6110-based restriction fragment length polymorphism pattern during the transmission of Mycobacterium tuberculosis. J Clin Microbiol (2002) 1.55

Knee surgery recovery: Post-operative Quality of Recovery Scale comparison of age and complexity of surgery. Acta Anaesthesiol Scand (2014) 1.54

Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med (1984) 1.52

Herpes simplex virus interstitial nephritis in a renal allograft. Clin Nephrol (1990) 1.52

Genotyping of Mycobacterium tuberculosis with additional markers enhances accuracy in epidemiological studies. J Clin Microbiol (1996) 1.51

Impact of social interactions in the community on the transmission of tuberculosis in a high incidence area. Thorax (1999) 1.50

Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis (1997) 1.50

Surveillance for surgical site infections: the uses of antibiotic exposure. Infect Control Hosp Epidemiol (1994) 1.48

Secular trends in preterm birth: a hospital-based cohort study. JAMA (1998) 1.48

Critical pediatric equipment availability in Canadian hospital emergency departments. Ann Emerg Med (2001) 1.46

A pharmacodynamic assessment of the impact of antihypertensive non-adherence on blood pressure control. Pharmacoepidemiol Drug Saf (2000) 1.45

Staphylococcus aureus bacteremia in diabetic patients. Endocarditis and mortality. Am J Med (1982) 1.44

Expression, characterization and subcellular localization of the Mycobacterium tuberculosis PPE gene Rv1917c. Tuberculosis (Edinb) (2001) 1.44

Demonstration of reinfection and reactivation in HIV-negative autopsied cases of secondary tuberculosis: multilesional genotyping of Mycobacterium tuberculosis utilizing IS 6110 and other repetitive element-based DNA fingerprinting. Tuberculosis (Edinb) (2001) 1.42

Recurrent bronchogenic cyst. An argument for complete surgical excision. Arch Surg (1991) 1.41

Automated analysis of paradoxical ribcage motion during sleep in infants. Pediatr Pulmonol (2002) 1.40

Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis (2006) 1.39

Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea. JAMA (1983) 1.39

Medicaid RBRVS payment system begins April 1. Tex Med (1992) 1.39

Can managed care control costs without controlling you? Tex Med (1992) 1.39

Electronic surveillance of antibiotic exposure and coded discharge diagnoses as indicators of postoperative infection and other quality assurance measures. Infect Control Hosp Epidemiol (1993) 1.39

TMA battles problems at Workers' Comp Commission. Tex Med (1992) 1.38

A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb (1992) 1.38

Wide-angle memories of close-up scenes. J Exp Psychol Learn Mem Cogn (1989) 1.37

Quantitative definition of bacteriuria. Am J Med (1983) 1.37

Digitized doctoring. A healthy mix of medicine and computers. Tex Med (1993) 1.37